These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18328861)

  • 1. Product safety compromises patient safety (an unjustified black box warning on ultrasound contrast agents by the Food and Drug Administration).
    Grayburn PA
    Am J Cardiol; 2008 Mar; 101(6):892-3. PubMed ID: 18328861
    [No Abstract]   [Full Text] [Related]  

  • 2. Overview of the 2008 Food and Drug Administration Advisory Committee on safety considerations in the development of ultrasound contrast agents.
    Asch FM; Weissman NJ
    Circulation; 2009 Apr; 119(14):1956-61. PubMed ID: 19364988
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety With Echocardiographic Contrast Agents.
    Muskula PR; Main ML
    Circ Cardiovasc Imaging; 2017 Apr; 10(4):. PubMed ID: 28377467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac ultrasound and extracorporeal life support: the two go together.
    J Am Soc Echocardiogr; 2015 Apr; 28(4):A18-9. PubMed ID: 25839156
    [No Abstract]   [Full Text] [Related]  

  • 5. Pro: The Food and Drug Administration Black box warning on droperidol is not justified.
    Habib AS; Gan TJ
    Anesth Analg; 2008 May; 106(5):1414-7. PubMed ID: 18420854
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety and efficacy of commercially available ultrasound contrast agents for rest and stress echocardiography a multicenter experience.
    Dolan MS; Gala SS; Dodla S; Abdelmoneim SS; Xie F; Cloutier D; Bierig M; Mulvagh SL; Porter TR; Labovitz AJ
    J Am Coll Cardiol; 2009 Jan; 53(1):32-8. PubMed ID: 19118722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the safety and clinical utility of contrast echocardiography.
    Chai SC; Tan PJ; Tong KL
    Singapore Med J; 2020 Apr; 61(4):181-183. PubMed ID: 31820006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDA response to droperidol black box warning editorials.
    Rappaport BA
    Anesth Analg; 2008 May; 106(5):1585. PubMed ID: 18420886
    [No Abstract]   [Full Text] [Related]  

  • 9. The radiopharmaceutical approval process: a day in the life.
    Kotz D
    J Nucl Med; 1995 Oct; 36(10):15N-16N, 22N, 30N. PubMed ID: 7562035
    [No Abstract]   [Full Text] [Related]  

  • 10. "Fast tracking" drug approvals: is consumer safety being compromised?
    Jacobsen K
    QRC Advis; 2000 Jun; 16(8):5-9. PubMed ID: 10977137
    [No Abstract]   [Full Text] [Related]  

  • 11. Con: The black box warning on droperidol should not be removed (but should be clarified!).
    Ludwin DB; Shafer SL
    Anesth Analg; 2008 May; 106(5):1418-20. PubMed ID: 18420855
    [No Abstract]   [Full Text] [Related]  

  • 12. Interventional Echocardiography Meets Structural Heart Disease: Speed Dating in DC.
    J Am Soc Echocardiogr; 2017 Feb; 30(2):A19. PubMed ID: 28164804
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug-review deadlines and safety problems.
    Carpenter D; Zucker EJ; Avorn J
    N Engl J Med; 2008 Mar; 358(13):1354-61. PubMed ID: 18367738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety in numbers--monitoring risk in approved drugs.
    Okie S
    N Engl J Med; 2005 Mar; 352(12):1173-6. PubMed ID: 15788493
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessing the cardiovascular safety of diabetes therapies.
    Goldfine AB
    N Engl J Med; 2008 Sep; 359(11):1092-5. PubMed ID: 18784098
    [No Abstract]   [Full Text] [Related]  

  • 16. Era of faster FDA drug approval has also seen increased black-box warnings and market withdrawals.
    Frank C; Himmelstein DU; Woolhandler S; Bor DH; Wolfe SM; Heymann O; Zallman L; Lasser KE
    Health Aff (Millwood); 2014 Aug; 33(8):1453-9. PubMed ID: 25092848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Has the food and drug administration changed the drug approval process?
    Somberg JC
    Am J Ther; 2011 May; 18(3):179. PubMed ID: 21566467
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug safety special: the safety catch.
    Wadman M
    Nature; 2005 Mar; 434(7033):554-6. PubMed ID: 15800591
    [No Abstract]   [Full Text] [Related]  

  • 19. "Black box" 101: How the Food and Drug Administration evaluates, communicates, and manages drug benefit/risk.
    Murphy S; Roberts R
    J Allergy Clin Immunol; 2006 Jan; 117(1):34-9. PubMed ID: 16387581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Black Box" warning labels and drug withdrawals.
    Thomas JA
    Toxicol Appl Pharmacol; 2002 Sep; 183(2):81. PubMed ID: 12387746
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.